The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't

Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery

NPPA, with this price regulation, has re-assured the availability of medicines at fair prices to the public

Premchand Godha's strategy for IPCA has not changed, it's about being integrated and focusSING on profitability

Centre has announced two schemes to reduce import dependence in medicine manufacturing. Will they work this time?

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

Stocks to watch today on November 18: Lakshmi Vilas Bank, DLF, Tanla Platforms and  Eveready Industries among others are the top stocks to watch out for in Wednesday's trading session

Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week

Dalal Street today: IndusInd Bank, followed by SBI, L&T, Axis Bank, HDFC twins, Kotak Bank and ICICI Bank were among the top losers today. On the other hand, Asian Paints, Reliance Industries, Titan, Bajaj Finance and Sun Pharma were trading with gains

India Stock Market Highlights Today: Global equities were buoyed today amid upbeat domestic economic data and rally in stocks in anticipation of better earnings reports

Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively

The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients

In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route

Cipla's research and development department is working on a couple of therapies that can be used in the treatment of COVID-19 and it could consider entering into marketing collaborations with companies that are currently developing vaccines for COVID-19

Several European countries have said they are experiencing shortages of the drug, whose global stock has been secured almost entirely by the United States

Prime Minister Narendra Modi on Wednesday entered his 20th consecutive year as head of the democratically elected government

The FDA released the guidance laying out more stringent recommendations for drugmakers hoping to apply for an emergency use authorization (EUA) for their experimental vaccines

Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir

As part of the settlement, Celgene has agreed to provide Dr Reddy's with a licence to sell volume-limited amounts of generic lenalidomide capsules in the US after March 2022 subject to regulatory approval

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)